Litha Healthcare Grp Ltd - CHANGE TO THE BOARD OF DIRECTORS AND AUDIT COMMITTEE

LITHA HEALTHCARE GROUP LIMITED
Incorporated in the Republic of South Africa
(Registration number 2006/006371/06)
Share code: LHG
ISIN: ZAE000144671
("Litha" or "the Company")


CHANGE TO THE BOARD OF DIRECTORS AND AUDIT COMMITTEE


In compliance with the JSE Limited     Listings   Requirements,   the
following information is disclosed:


Mark Beaudet and Mark Nawacki have been appointed as non-executive
directors of Litha with effect from 11 July 2012.


Mark Beaudet is a Canadian citizen has been a co-founder, Director

and Vice President of Sales and Marketing for Paladin Labs Inc.

On August 18 2011, Mr Beaudet assumed the duties of President and

Chief Executive Officer of Paladin Labs Inc. on an interim basis.

Prior to his work with Paladin, Mr Beaudet held marketing

management positions at Procter & Gamble Canada and Pizza Hut

Canada. Mr Beaudet holds a BComm in Marketing and Entrepreneurship
from McGill University.


Mark Nawacki is a Canadian citizen and holds responsibility for

all business, corporate and product development activities at

Paladin Labs Inc. Prior to joining Paladin, Mr Nawacki held

progressively senior leadership positions at Pharmacia, a global

top 10 pharmaceutical company that is now part of Pfizer Inc. Mr

Nawacki holds a BA in International Relations and Russian and East

European Studies from the University of Toronto (Trinity) and a

MBA also from the University of Toronto, and is a Canadian-
designated Chartered Accountant.


Gerardus (Gert) Hoogland has been appointed an executive

director to the board of Litha with effect from 11 July 2012.


Gerardus is a medical doctor and MBA graduate of the Institute d

Administration des Affaires - France (INSEAD). Dutch-born Gert

started his working career at the University of Amsterdam as a
Research Fellow in Experimental Cardiology.


Gert founded Pharmaplan in 1996 in order to serve specialty

pharmaceutical companies globally as a way to enter South Africa

through Pharmaplans virtual subsidiary concept. Pharmaplan has

since   developed    into   the    countrys   premier  specialty

pharmaceutical company, representing a number of high profiled

blue chip research and development based principals.


Andrew Bonamour remains on the Litha board, but has resigned as
Chairman and is replaced by Nkululeko Sowazi.

Nkululeko Sowazi has resigned as a member of the audit committee

of Litha. Both of these changes are effective from 11 July 2012.

Midrand
11 July 2012

Sponsor

RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 11/07/2012 04:15:00 Supplied by www.sharenet.co.za                     
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.